Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 134 (2) , 213-219
- https://doi.org/10.1016/s0002-8703(97)70127-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Thrombolytic Therapy of Peripheral Arterial Occlusion With Recombinant StaphylokinaseCirculation, 1995
- A Randomized Trial of Recombinant Staphylokinase Versus Alteplase for Coronary Artery Patency in Acute Myocardial InfarctionCirculation, 1995
- Achieving optimal reperfusion without adjunctive antithrombotic therapy: Novel thrombolytic dosing strategiesJournal of Thrombosis and Thrombolysis, 1995
- Novel and innovative dosing regimens in thrombolytic therapy for acute myocardial infarctionJournal of Thrombosis and Thrombolysis, 1995
- Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential?Blood, 1994
- High Yield Production and Purification of Recombinant Staphylokinase for Thrombolytic TherapyNature Biotechnology, 1994
- Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarctionJournal of the American College of Cardiology, 1994
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987